| View |
|
DR-XY30979
|
Multivitamins + Minerals
|
Ocuvite Preservision
|
7,160IU, 113mg, 100IU, 17.4mg, 0.4mg
|
Film Coated Tablet
|
Vitamin/Mineral
|
Nutra Manufacturing
|
U.S.A.
|
Automatic Renewal
|
10 March 2023
|
22 April 2028
|
| View |
|
DR-XY30980
|
5% Dextrose In Water
|
None
|
5 g/100 mL
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
19 November 2020
|
17 August 2025
|
| View |
|
DR-XY30981
|
5% Dextrose In 0.3% Sodium Chloride
|
None
|
5% in 0.3%
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
19 November 2020
|
17 August 2025
|
| View |
|
DR-XY30982
|
10% Dextrose In Water
|
None
|
10 g/100 ml
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
19 November 2020
|
17 August 2025
|
| View |
|
DR-XY30983
|
5% Dextrose In Lactated Ringer'S
|
None
|
See reverse of CPR
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
19 November 2020
|
17 August 2025
|
| View |
|
DR-XY30984
|
Lactated Ringer'S Solution
|
None
|
See reverse of CPR
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
19 November 2020
|
17 August 2025
|
| View |
|
DR-XY30985
|
Balanced Multiple Maintenance Solution With 5% Dextrose
|
None
|
see reverse of CPR
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
19 November 2020
|
17 August 2025
|
| View |
|
DR-XY30986
|
5% Dextrose In 0.9% Sodium Chloride
|
None
|
5 g/900 mg per 100 mL
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
19 November 2020
|
17 August 2025
|
| View |
|
DR-XY30988
|
0.9% Sodium Chloride
|
None
|
900 mg/100 ml
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
19 November 2020
|
17 August 2025
|
| View |
|
DR-XY30989
|
Balanced Multiple Maintenance Solution with 5%
Dextrose (see reverse formulation)
|
None
|
see reverse of CPR
|
Solution for IV Infusion (Pediatric
Solution)
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
19 November 2020
|
17 August 2025
|
| View |
|
DR-XY30991
|
Balanced Multiple Replacement Solution With 5% Dextrose
|
None
|
see reverse of CPR
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
20 October 2020
|
17 August 2025
|
| View |
|
DR-XY31003
|
Ibandronic Acid
|
Bondronat
|
6 mg/ 6 mL
|
Concentrate Solution For Iv Infusion
|
Bisphosphonate
|
Roche Diagnostics GmbH
|
Germany
|
Automatic Renewal
|
24 July 2020
|
19 August 2025
|
| View |
|
DR-XY31024
|
Mitomycin
|
Mytoxid
|
10 mg
|
Powder For Injection (I.V.)
|
-
|
Korea United Pharm. Inc.
|
Korea
|
-
|
13 April 2020
|
24 August 2025
|
| View |
|
DR-XY31035
|
Omeprazole (as sodium)
|
None
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
-
|
Standard Chem. & Pharm. Co., Ltd.
|
Taiwan
|
-
|
07 December 2021
|
01 September 2025
|
| View |
|
DR-XY31042
|
Hyoscine-N-Butylbromide
|
Fucon
|
10 mg
|
Tablet
|
-
|
Y.S.P. Industries (M) Sdn. Bhd.
|
Malaysia
|
-
|
10 November 2021
|
19 May 2025
|
| View |
|
DR-XY31050
|
Prednisone
|
Biopred
|
10 mg
|
Film-Coated Tablet
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Compliance ((Automatic Renewal)
|
04 November 2021
|
05 September 2025
|
| View |
|
DR-XY31054
|
Aciclovir
|
Terclovir
|
400 mg
|
Tablet
|
Antiviral (Nucleosides and Nucleotides excl. Reverse Transcriptase Inhibitors)
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
13 June 2022
|
06 September 2027
|
| View |
|
DR-XY31055
|
Acyclovir
|
Terclovir
|
200 mg
|
Tablet
|
Antiviral (Nucleosides and Nucleotides excl. Reverse Transcriptase Inhibitors)
|
Drugmakers lab.Inc
|
Philippines
|
Renewal
|
23 May 2022
|
06 September 2027
|
| View |
|
DR-XY31057
|
Sildenafil (As Citrate)
|
Andros
|
25 mg
|
Film-Coated Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
19 June 2020
|
09 July 2025
|
| View |
|
DR-XY31067
|
Sodium Chloride
|
Unbranded
|
50 mg/mL (5%)
|
Ophthalmic Solution
|
Hypertonic Solution
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
31 October 2023
|
06 February 2029
|